We evaluated the effect of vaccination with anti-COVID-19 vaccine EpiVacCorona on serum antimicrobial activity, formation of specific IgG antibodies, and expression of some antimicrobial peptides. Antimicrobial activity of the serum from 55 volunteers towards S. aureus cells was measured spectrophotometrically; IgG-antibodies against SARS-CoV-2 antigen were assayed by ELISA; expression of genes encoding antimicrobial peptides LL37, HBD1, and HBD2 was evaluated by PCR with reverse transcription. Total antimicrobial serum activity and activity of its low-molecular-weight fraction containing antimicrobial peptides demonstrated an inverse correlation. Both activities after vaccination increased in case of low initial values, but decreased in case of high initial values. The vector of change of specific IgG antibodies to coronavirus inversely correlated with the vector of change of activity of antimicrobial peptide fraction. The expression of genes of antimicrobial peptides LL37, HBD1, and HBD2 looked like normal distribution depending on activities of the antimicrobial peptides in the corresponding sera.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arzumanyan VG, Ozhovan IM. Modified method for evaluation of plasma membrane integrity in eukaryotic cell. Bull. Exp. Biol. Med. 2002;134(1):103-105. https://doi.org/10.1023/A:1020641629319
Arzumanyan VG, Mikhajlova NA, Artemeva TA, Butovchenko LM, Vartanova NO, Erofeeva TV, Kostinov MP, Kiselevskij MV, Polishchuk VB. Patent RU No 2686337. Method of determining antimicrobial activity of whole serum and fraction of its antimicrobial peptides. Byull. No 12. Published April 25, 2019.
Arzumanian V, Erofeeva T, Ixanova A, Zhigalkina P, Svitich O. Activity of antimicrobial peptide fractions of human serum and saliva against clinically important yeasts. Curr. Top. Peptide Protein Res. 2019;20:9-15. https://doi.org/10.31300/CTPPR.20.2019.9-15
Arzumanian V, Shmeleva O, Michailova N. Elevated activity levels of serum antimicrobial peptides in mice as response to immunization with yeast antigens. Med. Mycol. Open Access. 2017;3(1):23. https://doi.org/10.21767/2471-8521.100023
Dixon BM, Barker T, McKinnon T, Cuomo J, Frei B, Borregaard N, Gombart AF. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res. Notes. 2012;5:575. https://doi.org/10.1186/1756-0500-5-575
Friberg C, Haaber JK, Vestergaard M, Fait A, Perrot V, Levin BR, Ingmer H. Human antimicrobial peptide, LL-37, induces non-inheritable reduced susceptibility to vancomycin in Staphylococcus aureus. Sci. Rep. 2020;10(1):13121. https://doi.org/10.1038/s41598-020-69962-4
Geitani R, Ayoub Moubareck C, Touqui L, Karam Sarkis D. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. BMC Microbiol. 2019;19(1):54. https://doi.org/10.1186/s12866-019-1416-8.
Jansen PA, Rodijk-Olthuis D, Hollox EJ, Kamsteeg M, Tjabringa GS, de Jongh GJ, van Vlijmen-Willems IM, Bergboer JG, van Rossum MM, de Jong EM, den Heijer M, Evers AW, Bergers M, Armour JA, Zeeuwen PL, Schalkwijk J. Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS One. 2009;4(3):e4725. https://doi.org/10.1371/journal.pone.0004725
Kaltsa G, Bamias G, Siakavellas SI, Goukos D, Karagiannakis D, Zampeli E, Vlachogiannakos J, Michopoulos S, Vafiadi I, Daikos GL, Ladas SD. Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis. Ann. Gastroenterol. 2016;29(1):63-70.
Kang J, Dietz MJ, Li B. Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms. PLoS One. 2019;14(6):e0216676. https://doi.org/10.1371/journal.pone.0216676
Midorikawa K, Ouhara K, Komatsuzawa H, Kawai T, Yamada S, Fujiwara T, Yamazaki K, Sayama K, Taubman MA, Kurihara H, Hashimoto K, Sugai M. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 2003;71(7):3730-3739. https://doi.org/10.1128/IAI.71.7.3730-3739.2003
Ryzhikov AB, Ryzhikov EA, Bogryantseva MP, Usova SV, Danilenko ED, Nechaeva EA, Pyankov OV, PyankovaOG, Gudymo AS, Bodnev SA, Onkhonova GS, Sleptsova ES, Kuzubov VI, Ryndyuk NN, Ginko ZI, Petrov VN, Moiseeva AA, Torzhkova PYU, Pyankov SA, Tregubchak TV, Antonec DV, Gavrilova EV, Maksyutov RA. A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “Epivaccorona” vaccine for the prevention of COVID-19, in volunteers aged 18-60 years (Phase I-II). Rus. J. Infect. Immun. 2021;11(2):283-296. https://doi.org/10.15789/2220-7619-ASB-1699
Wei Z, Wu S, Xia J, Shao P, Sun P, Xiang N. Enhanced antibacterial activity of hen egg-white lysozyme against Staphylococcus aureus and Escherichia coli due to protein fibrillation. Biomacromolecules. 2021;22(2):890-897. https://doi.org/10.1021/acs.biomac.0c01599
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 173, No. 3, pp. 350-356, March, 2022
Rights and permissions
About this article
Cite this article
Arzumanyan, V.G., Bystritskaya, E.P., Kolyganova, T.I. et al. Antimicrobial Activity of the Serum before and after Vaccination with EpiVacCorona. Bull Exp Biol Med 173, 354–360 (2022). https://doi.org/10.1007/s10517-022-05548-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-022-05548-6